Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.31SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-613.77China
BA.2.31SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BA.2.31SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.31SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BA.2.31NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BA.2.31NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.31NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
BA.2.31NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.31NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BA.2.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.31NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.31NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.2.31NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.31NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.31NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.31NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.31NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.2.31NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.31NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.31ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-22371Japan
BA.2.31ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
BA.2.31ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-19431.6Japan
BA.2.31ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
BA.2.31ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.31ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
BA.2.31SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.31SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
BA.2.31SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
BA.2.31SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
BA.2.31SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
BA.2.31SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
CP.1.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
CP.1.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used